Calcium channel blockers in older patients show 70% greater risk of cancer -- Pahor study.
Executive Summary
CALCIUM ANTAGONISTS SHOW 70% GREATER CHANCE OF CANCER DEVELOPMENT in older patients than in patients not taking calcium channel blockers, according to the results of a study published in the Aug. 24 issue of the Lancet by Marco Pahor, et al., University of Tennessee-Memphis. The authors suggest that a possible mechanism for the link between CCBs and cancer is that calcium antagonists "inhibit apoptosis in various experimental models," thereby possibly interfering with the prevention of cancer.